Roche Q1 Sales Up 9%; Raises FY Outlook

01:52 EDT 17 Apr 2019 | FinanzNachrichten

SOUTH SAN FRANCISCO (dpa-AFX) - Swiss drug major Roche (RHHBY) reported that its group sales for the first-quarter rose 9 percent to 14.83 billion Swiss francs from last year's 13.58 billion franc...

Original Article: Roche Q1 Sales Up 9%; Raises FY Outlook


More From BioPortfolio on "Roche Q1 Sales Up 9%; Raises FY Outlook"

Quick Search


Relevant Topics

Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...